Is your research grant running out in 2024? Don’t let it go to waste - plan ahead for your 2025 projects today! With Source Genomics, securing funds for your future research is simple and hassle-free. Get in touch for a quote now 👉 https://lnkd.in/eRm5RyWZ #Genomics #SangerSequencing #NGS #Sequencing #GenomeMapping #Biomarkers #BiomarkerDiscovery #DrugDiscovery #Multiomics #Research #TheSequencingPeople
Source BioScience
Biotechnology Research
Nottingham, Nottinghamshire 11,797 followers
Industry-leading provider of Genomic and Histopathology services, including Cellular & Digital Pathology.
About us
Source BioScience, comprised of Source LDPath and Source Genomics, provides industry-leading laboratory services in Genomics and Histopathology, partnering with biotechnology, pharmaceutical, healthcare and academia. Source LDPath provides an end-to-end clinical diagnostic service, from histopathology, including digital pathology and AI, through to molecular diagnostic services. Source LDPath already supports over 85 NHS Trusts and a comprehensive network of Private Healthcare clinics to expand their diagnostic capabilities, ensuring diagnostic results are delivered within clinically actionable timeframes. Source LDPath brings pioneering expertise in digital pathology and AI implementation, helping NHS pathology departments digitise their workflows for streamlined operations and greater diagnostic reporting capacity, tailoring integration touchpoints to the specific requirements of the Hospital or Trust. • Cellular and digital pathology wet laboratory processing • Reporting - access a pool of over 200 specialist consultant pathologists • MDM and Second Opinions • Digital Implementation Support with AI integration • Connectivity and LIMS integration with Source HIVE™ Source Genomics provides a broad portfolio of multi-omic services, delivering high-quality data in Genomics, Spatial Transcriptomics, Proteomics and Epigenomics. Market-leaders in Sanger Sequencing and Next-Generation Sequencing Services, Source Genomics delivers bespoke laboratory expertise to excel your project at rapid turnaround times. • Sanger Sequencing • NGS - WGS, WES, RNA-seq • Oxford Nanopore Sequencing • Olink proteomics • Optical Genome Mapping • 10x Genomics Visium • Bioinformatics • And more Contact us today at [email protected].
- Website
-
http://www.sourcebioscience.com/
External link for Source BioScience
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Nottingham, Nottinghamshire
- Type
- Privately Held
- Specialties
- DNA Sequencing, Genotyping, Gene Expression, Antibodies, Histopathology, Diagnostic testing, Next Generation Sequencing, Bioinformatics, Clinical trials, Drug development, Digital Pathology, healthcare services, diagnostics, life sciences, laboratory services, NHS, Private Healthcare, Cellular Pathology, and Genomics
Locations
Employees at Source BioScience
Updates
-
Source BioScience reposted this
Adoption of digital pathology has the potential to transform histopathology services within the NHS, but a cohesive strategy is required to realise the full benefits nationwide. Source BioScience (Source LDPath) looks at digital adoption so far and previews key recommendations from a forthcoming white paper from a National Working Group for Digital Pathology.
-
Time is running out to take advantage of our exclusive year-end savings! 💵 10% EXTRA Rapid Sequencing eVouchers 💵 25% EXTRA Vouchers for Rapid Whole Plasmid Sequencing 💵 25% off Olink Explore 3k, Explore HT and Target 48/96 Proteomics Assays Contact us today to explore our year-end offers and see how we can become your trusted partner in genomics 👉 https://lnkd.in/gZ6yeAwC #Genomics #SangerSequencing #NGS #Proteomics #Biomarkers #BiomarkerDiscovery #DrugDiscovery #Multiomics #LifeScience #TheSequencingPeople
-
Accelerating towards digital 🖥️ Source LDPath, a part of Source BioScience, is on this month’s Pathology In Practice cover! Read our feature piece in Practice article here 👉 https://lnkd.in/esMbn7GW #DigitalPathology #PathologyInPractice #NHS #Histopathology #AI #BiomedicalScience #AtTheHeartOfHealthcare #Healthcare #PrivateHealthcare #Pathology #CellularPathology #HealthEconomics #DiagnosticBacklogs
-
🎉 Celebrating 20+ years of Genomic Sequencing progression! 🎉 At Source Genomics, we are committed to advancing the field of genomics and providing our partners with cutting-edge sequencing solutions. Over the past 20+ years, we have continually evolved, incorporating high-throughput sequencing, advanced data analysis, and Olink proteomics into our services. 🧬 Explore our timeline below to discover our key milestones and the ongoing evolution of our sequencing and multi-omic service portfolio 👉 https://lnkd.in/e9_z2F_g #Genomics #TheSequencingPeople #SangerSequencing #NGS #Proteomics #Multiomics #Biomarkers #BiomarkerDiscovery #DrugDiscovery #DNA #LifeScience
-
We are proud to partner with Stilla Technologies. Together, leading the way in the UK and Ireland as the first provider to bring the NIO Digital PCR System to researchers. At Source Genomics, we’re committed to empowering researchers with the tools they need to make life-changing discoveries. Read the press release here 👉 https://lnkd.in/evPu_h_Z #MolecularDiagnostics #GeneTherapy #StillaTechnologies #dPCR #Genomics #TheSequencingPeople
-
Today is the final day of the 11th Digital Pathology & AI Congress! 👋 Meet the Source LDPath team at stand #30 to learn about the cost-benefit analysis of implementing a digital pathology workflow in your laboratory or department to enable enhanced patient care and further drug discovery. For more information about Source LDPath, click here 👉https://lnkd.in/gTuMxFRb #DigitalPathology #AI #BiomedicalScience #AtTheHeartOfHealthcare #Healthcare #Histopathology #PrivateHealthcare #Pathology #NHS #CellularPathology #DigiPathLondon
-
Come and say hello to the Source Genomics team today at the CONEXEN Cambridge event 👋 Tonight's panel discusses "Pathways to Possibility: Navigating career transitions in Life Sciences and Biopharma." Join us for an evening surrounded by incredible people, and let’s make it a night to remember. Can't make it? For more information about Source Genomics, click here 👉 https://lnkd.in/edfMMxmW #CONEXEN #HealthcareInnovation #Networking #Cambridge #Genomics #SangerSequencing #NGS #TheSequencingPeople
-
The Source LDPath team is onsite at the 11th Digital Pathology & AI Congress! 👋 Talk to our Digital Pathology & AI experts today to understand the cost-benefit analysis of implementing a digital pathology workflow in your laboratory or department to enable enhanced patient care and further drug discovery. For more information about Source LDPath, click here 👉https://lnkd.in/g9GA2deR 🗣️ Stand 30 📆 11th - 12th December 2024 📍 Hilton London Metropole #DigitalPathology #AI #BiomedicalScience #AtTheHeartOfHealthcare #Healthcare #Histopathology #PrivateHealthcare #Pathology #NHS #CellularPathology #DigiPathLondon
-
Missed this? We are pleased to release our latest whitepaper: ‘Accelerating NHS Digital Pathology Adoption: A Strategic Roadmap’. This whitepaper takes a unique look at the digital pathology landscape, with contributions from leading stakeholders from across a range of UK organisations in the daily operations of histopathology service delivery. The main aim of the publication is to complement ongoing initiatives within the NHS and related services to accelerate NHS-wide digital transformation. 𝗞𝗲𝘆 𝘁𝗼𝗽𝗶𝗰𝘀 𝗶𝗻𝗰𝗹𝘂𝗱𝗲: ✔️ Current barriers to adoption ✔️ Implementation strategies to support seamless integration across departments ✔️ 8 actionable recommendations to build upon for large-scale success Read the whitepaper here 👉 https://lnkd.in/ehMwRVQe #Healthcare #LifeScience #Pathology #PatientCare #Histopathology #PrivateHealthcare #CellularPathology #BiomedicalScience #DigitalPathology #NHS #NHSDigitalPathology #Whitepaper